Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02707991 · ClinicalTrials.gov registry record · NA

Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT02707991: Completed NA study, sponsored by Johns Hopkins University.

NCT02707991 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02707991, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

Effective all-oral medications are finally available to cure hepatitis C virus, which affects more than 4 million Americans and one-in-four people living with HIV. However, many barriers exist that prevent people with HIV/HCV co-infection from getting this curative treatment, including low knowledge, competing demands, and drug interactions with HIV medications. This study evaluates if a hepatitis C nurse case management intervention in an HIV primary care clinic will improve patient attendance to hepatitis C care and help people start hepatitis C treatment earlier. Half of the participants will receive brief case management with a nurse, while the other half will receive usual clinic care.

Primary Outcome

This will be assessed based on the number of participants who attend an appointment at the Viral Hepatitis Clinic within 60 days of enrolling in the study. A participant is considered "linked to care" if he/she attends an appointment at the clinic. A participant is considered "not linked to care" if he/she does not attend an appointment at the clinic. Whether a participant linked to care will be determined by looking at the medical record, where all attended appointments are documented. If no at

Interventions

  • BEHAVIORAL Nurse Case Management

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2016-07
Est. Completion 2018-08
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT02707991 record still lists

NCT02707991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Nurse Case Management is the first listed.

NCT02707991 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02707991 about?

NCT02707991 is a clinical study titled "Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection". Effective all-oral medications are finally available to cure hepatitis C virus, which affects more than 4 million Americans and one-in-four people living with HIV. However, many barriers exist that prevent people with HIV/HCV co-infection from getting this curative treatment, including low knowledge...

What is the current status of trial NCT02707991?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2016-07. Estimated completion is 2018-08.

What interventions are being tested in trial NCT02707991?

The interventions under investigation include: Nurse Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT02707991?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02707991's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02707991, the US trial registry maintained by the National Library of Medicine. NCT02707991 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.